Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis
Clinical trial NCT02226549 · COMPLETED
Trial details
- NCT number
- NCT02226549
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-02-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.